News | August 15, 2024
HCAH Kolkata Center achieves NABH Certification
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
The partnership marks a significant milestone in integrating digital health education into medical curricula
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
For the 2024 outlook, sales growth is now expected to be 22-28% at CER
EBITDA for Q1 FY25 is at Rs. 100 crore compared to Rs. 32 crore in the previous year
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Our centers are performing as expected or even better
CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases
Subscribe To Our Newsletter & Stay Updated
